The largest database of trusted experimental protocols

4 protocols using aj518

1

Protein Expression Analysis in Cell and Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
The L02 cells and liver tissue samples were prepared as described above, and total protein was extracted. Western blotting was used to detect the target proteins of each sample, such as phospho-ERK1/2 (p-ERK1/2) (AM071, Beyotime), ERK1/2 (AF1051, Beyotime), phospho-p38 MAPK (Thr180) (p-p38) (AF5884, Beyotime), p38 MAPK (p38) (AF7668, Beyotime), phospho-JNK1/2 (Thr183/Tyr185) (p-JNK) (AF5860, Beyotime), JNK (AJ518, Beyotime), GAPDH (AF1186, Beyotime), phospho-AMPKα (Thr172) (p-AMPKα) (2535T, CST), AMPKα (t-AMPK) (2532S, CST), phospho-ACC (Ser79) (p-ACC) (3661S, CST), and ACC (t-ACC) (3676T, CST). The target protein bands of western blots were analyzed and quantified. The levels of p-AMPKα, p-ACC p-ERK1/2, p-p38 and p-JNK were normalized to those of AMPKα, ACC, ERK1/2, p38 and JNK, respectively, and are presented as the fold change compared to the control treatment.
+ Open protocol
+ Expand
2

Antibody Characterization for Cellular Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies were used as follows: anti-VPS35 (1:10,000, ab157220, Abcam, USA), anti-E-cadherin (1:10,000, ab40772, Abcam, USA), anti-N-cadherin (1:1000, 13116, Cell Signaling Technology, USA), anti-β-actin (1:2000, TA-09, ZSGB-BIO, China), anti-GAPDH (1:2000, AG019, Beyotime, China), anti-ROCK1 (1:500, WL01761, Wanleibio, China), anti-JNK (1:1000, GTX133806, Gene Tex, USA), anti-p-JNK (1:1000, AJ518, Beyotime, China), anti-Na/K ATPase (1:2000, 619736, ZEN BIO, China), anti-Frizzled 2 (1:1000, 24272-1-AP, Proteintech, USA), anti-ROR1 (1 μg/ml, AF2000, R&D system, USA), anti-MMP9 (1:1000, S1241, Bioworld, USA), p62 (1:1000, 5114, Cell Signaling Technology, USA), anti-Rac (1:500, WL02851, Wanleibio, China), anti-RhoA (1:500, WL02853, Wanleibio, China), anti-Rac (1:1000, ab76535, Abcam, USA), anti-RhoA (1:1000, bs-5330R, Bioss, USA), anti-p-p62 (1:1000, GTX128171, Gene Tex, USA), anti-FZD1 (1:1000, GTX108181, Gene Tex, USA).
+ Open protocol
+ Expand
3

Immunoblotting Analysis of Cell Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunoblotting analysis was performed as described.9 5% BSA and non‐fat milk were used as blocking reagent. The corresponding antibodies mainly included ZCCHC14 (ab‐150591, Abcam, USA), P42/44 (AM076, Beyotime, China), p‐P42/44 (AM071, Beyotime, China), cyclinD1 (AC853, Beyotime, China), MMP7 (D4H5; 3801, Cell Signaling, USA), MMP9 (D6O3H; 13 667, Cell Signaling, USA), GADPH (ab8245, Abcam, USA), JNK (AJ518; Beyotime, China), P‐JNK (AJ516, Beyotime, China), P38MAPK (AM065, Beyotime, China) and p‐P38MAPK (AM063, Beyotime, China),
+ Open protocol
+ Expand
4

Signaling Pathway Activation by LPH

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cells were seeded on 6 cm dishes at a concentration of 2 × 105 cells per well and incubated in growth medium until confluency; then, the cells were serum-starved in α-MEM for 12 h. Then, 500 μg/mL of LPH was added to the culture medium before incubating for different time periods (0.5, 1, 2, 4, 8, 12, 24, and 36 h) to detect activation of the signaling pathway by Western blotting. Primary rabbit antibodies of extracellular signal regulated kinase 1/2 (ERK, 137F5, CST), phospho-ERK1/2 (Thr202/Try204, D13.14.4E, CST), p38 (AF1111, Beyotime), phospho-p38 (Thr180/Try182, AF5887, Beyotime), jun N-amino-terminal kinase (JNK, AJ518, Beyotime), phospho-JNK (Thr183/Try185, AF5860, Beyotime), Akt (C67E7, CST), phospho-Akt (Ser473, D9E, CST), and the loading control α/β-tubulin were used to examine the changes in MAPK and Akt signaling pathways.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!